The Oncology Institute Q2 EPS $(0.08) Misses $(0.06) Estimate, Sales $161.282M Beat $155.193M Estimate
The Oncology Institute (NASDAQ:TOI) reported quarterly losses of $(0.08) per share which missed the analyst consensus estimate of $(0.06) by 33.33 percent. This is a 46.67 percent increase over losses of $(0.15) per
The Oncology Institute made more money than expected from selling services, but lost more money per share than experts predicted. When a company beats on sales but misses on losses, it shows the business is growing but still struggling to be profitable.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.